Share:
Share this content in WeChat
X
EXPERIENCE EXCHANGES
The feasibility study of diffusion weighted magnetic resonance imaging in predicting peritoneal cancer index in patients with advanced ovarian cancer
WAN Zaixin  LU Yubo  LI Dan 

Cite this article as: Wan ZX, Lu YB, Li D. The feasibility study of diffusion weighted magnetic resonance imaging in predicting peritoneal cancer index in patients with advanced ovarian cancer[J]. Chin J Magn Reson Imaging, 2021, 12(2): 83-85. DOI:10.12015/issn.1674-8034.2021.02.019.


[Abstract] Objective To evaluate the potential of diffusion weighted MRI in predicting peritoneal cancer index (PCI) in patients with advanced ovarian cancer and whether patients can perform complete tumor cell extinction. Materials andMethods We retrospectively included 25 patients with advanced ovarian cancer (FIGO stage IIb and above) who received cytoreductive surgery at Dandong Traditional Chinese Medicine Hospital from June 2016 to May 2018. Included patients underwent a 1.5 T magnetic resonance diffusion-weighted imaging scan before surgery [the scan sequence in DW-MRI examination includes T1 and T2-weighted imaging sequence, contrast-enhanced T1-weighted and diffusion-weighted imaging (b=0, 1000 s/mm2)] sequence. Two associate chief radiologists performed independent reading without knowing the pathology of the operation.Results The study found that the results of the readers were consistent with the intraoperative peritoneal cancer index, and the intra-group correlation coefficient reached 0.90 (95% confidence interval: 0.64—0.96). Reader 1 (area under the curve=0.96) and reader 2 (area under the curve=0.98) magnetic resonance imaging peritoneal cancer index and intraoperative peritoneal cancer index (area under the curve=0.92) display and complete cytoreductive surgery similar predictions.Conclusions In patients with advanced ovarian cancer, DW-MRI can be regarded as a powerful non-invasive selection tool in the PCI score, which is of great significance for determining whether to perform complete cytoreductive surgery.
[Keywords] cytoreductive surgery;diffusion weighted imaging;magnetic resonance imaging;ovarian cancer;peritoneal cancer

WAN Zaixin1*   LU Yubo1   LI Dan2  

1 Department of Radiology, Dandong Hospital of Traditional Chinese Medicine, Dandong 118000, China

2 Department of Radiology, Panjin Central Hospital, Panjin 124000, China

Wan ZX, E-mail: wanwanzai@126.com

Conflicts of interest   None.

Received  2020-03-27
Accepted  2020-11-25
DOI: 10.12015/issn.1674-8034.2021.02.019
Cite this article as: Wan ZX, Lu YB, Li D. The feasibility study of diffusion weighted magnetic resonance imaging in predicting peritoneal cancer index in patients with advanced ovarian cancer[J]. Chin J Magn Reson Imaging, 2021, 12(2): 83-85. DOI:10.12015/issn.1674-8034.2021.02.019.

1
Lheureux S, Gourley C, Vergote I, et al. Epithelial ovarian cancer[J]. Lancet, 2019, 393(10177):1240-1253. DOI: 10.1016/S0140-6736(18)32552-2.
2
Yeung TL, Leung CS, Yip KP, et al. Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and molecular processes in cancer metastasis[J]. Am J Physiol Cell Physiol, 2015, 309(7): C444-456. DOI: 10.1152/ajpcell.00188.2015.
3
Abdel-Rahman O. A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery[J]. Int J Colorectal Dis, 2020, 35(4): 719-725. DOI: 10.1007/s00384-020-03525-x.
4
Iavazzo C, Fotiou A, Tsiatas M, et al. Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPEC[J]. Pleura Peritoneum, 2020, 5(1): 20190029. DOI: 10.1515/pp-2019-0029.
5
Xie YQ, Yang YL. Clinical study on self nursing intervention to improve cancer pain[J]. Infection Inflammation Repair, 2017, 18(3): 161-164. DOI: 10.3969/j.issn.1672-8521.2017.03.010.
6
Fu ZC, Liu JW, Fan JW. Progress of cytoreductive surgery combined with intraperitoneal hyperthermic perfusion chemotherapy for peritoneal metastasis of colorectal cancer[J]. Chin J Digest Surg, 2019, 18(8): 747-752. DOI: 10.3760/cma.j.issn.1673-9752.2019.08.008.
7
Wei W, Luo C, Yang J, et al. Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer[J]. J Control Release, 2018, 285(56): 187-199. DOI: 10.1016/j.jconrel.2018.07.010.
8
Alemanno G, Prosperi P, Di Bella A, et al. Bedside diagnostic laparoscopy for critically ill patients in the Intensive Care Unit: Retrospective study and review of literature[J]. J Minim Access Surg, 2019, 15(1): 56-62. DOI: 10.4103/jmas.JMAS_232_17.
9
Tsuyoshi H, Yashiro K, Yamada S, et al. Role of diagnostic laparoscopy in patients with large cell neuroendocrine carcinoma of the ovary with cancerous peritonitis: case report and review of the literature[J]. J Ovarian Res, 2019, 12(1): 95. DOI: 10.1186/s13048-019-0571-8.
10
Tentes AA, Tripsiannis G, Markakidis SK, et al. Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer[J]. Eur J Surg Oncol, 2003, 29(1): 69-73. DOI: 10.1053/ejso.2002.1380.
11
Gasimli K, Braicu EI, Richter R, et al. Prognostic and predictive value of the peritoneal cancer index in primary advanced epithelial ovarian cancer patients after complete cytoreductive surgery: Study of tumor bank ovarian cancer[J]. Ann Surg Oncol, 2015, 22(8): 2729-2737. DOI: 10.1245/s10434-014-4329-7.
12
Zhuang Y, Wang T, Zhang G. Diffusion-weighted magnetic resonance imaging (DWI) parameters in benign and malignant ovarian tumors with solid and cystic components[J]. J Coll Physicians Surg Pak, 2019, 29(2): 105-108. DOI: 10.29271/jcpsp.2019.02.105.
13
Zhu SB, Huang JL, Pan JH, et al. Evaluation of tumor vascular normalization in colorectal cancer mouse mode induced by recombinant human endostatin by intravoxel incoherent motion diffusion-weighted magnetic resonance imaging[J]. Chin J Oncology, 2019, 41(6): 421-428. DOI: 10.3760/cma.j.issn.0253-3766.2019.06.005.
14
Wang JJ, Wang WJ. Value of 3.0 T MRI multi-b value diffusion-weighted imaging combined with ADC value in the diagnosis of ovarian cancer[J]. Chin J CT & MRI, 2018, 16(7): 113-115. DOI: 10.3969/j.issn.1672-5131.2018.07.034.
15
Sugarbaker PH. Surgical responsibilities in the management of peritoneal carcinomatosis[J]. J Surg Oncol, 2010, 101(8): 713-724. DOI: 10.1002/jso.21484.
16
van de Vrie R, Rutten MJ, Asseler JD, et al. Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer[J]. Cochrane Database Syst Rev, 2019, 3(3): CD009786. DOI: 10.1002/14651858.CD009786.pub3.
17
Lampe B, Kroll N, Piso P, et al. Prognostic significance of Sugarbaker's peritoneal cancer index for the operability of ovarian carcinoma[J]. Int J Gynecol Cancer, 2015, 25(1): 135-144. DOI: 10.1097/IGC.0000000000000327.
18
Michielsen K, Dresen R, Vanslembrouck R, et al. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer[J]. Eur J Cancer, 2017, 83(15): 88-98. DOI: 10.1016/j.ejca.2017.06.010.
19
Rosendahl M, Harter P, Bjørn SF, et al. Specific regions, rather than the entire peritoneal carcinosis index, are predictive of complete resection and survival in advanced epithelial ovarian cancer[J]. Int J Gynecol Cancer, 2018, 28(2): 316-322. DOI: 10.1097/IGC.0000000000001173.
20
Ghisoni E, Katsaros D, Maggiorotto F, et al. A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience[J]. J Ovarian Res, 2018, 11(1): 42. DOI: 10.1186/s13048-018-0415-y.
21
Llueca A, Serra A, Rivadulla I, et al. Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index[J]. World J Surg Oncol, 2018, 16(1): 37. DOI: 10.1186/s12957-018-1339-0.

PREV Application of apparent diffusion coefficient histogram analysis in the grading of gastrointestinal stromaltumors
NEXT Solitary fibrous tumor/vascular pericytoma of lateral ventricle: A case report
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn